Harry de Koning (H J de Koning, Harry J De Koning, Harry J de Koning)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 30

Top Venues

International journal of cancer

Annals of internal medicine

Cancer medicine

Cancers

Erasmus MC

Erasmus MC (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Erasmus MC Jan 1o 1987

Netherlands

Professor :: Public Health

Education History

Erasmus MC Jan 1o 2008

Netherlands

PHD :: Public Health

Publications

Yuki Tomonaga, Koen de Nijs, Heiner C Bucher, Harry de Koning, Kevin Ten Haaf
Cost-effectiveness of risk-based low-dose computed tomography screening for lung cancer in Switzerland. International journal of cancer (2023)
Iakovos Toumazis, Pianpian Cao, Koen de Nijs, Mehrad Bastani, Vidit Munshi, Mehdi Hemmati, Kevin Ten Haaf, Jihyoun Jeon, Martin Carl Tammemägi, G Scott Gazelle, Eric J Feuer, Chung Yin Kong, Rafael Meza, Harry de Koning, Sylvia K Plevritis, Summer S Han
Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis. Annals of internal medicine 176 (3) (2023)
Iakovos Toumazis, Pianpian Cao, Koen de Nijs, Mehrad Bastani, Vidit Munshi, Mehdi Hemmati, Kevin Ten Haaf, Jihyoun Jeon, Martin Carl Tammemägi, G Scott Gazelle, Eric J Feuer, Chung Yin Kong, Rafael Meza, Harry de Koning, Sylvia K Plevritis, Summer S Han
Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis. Annals of internal medicine 176 (3) (2023)
Iakovos Toumazis, Pianpian Cao, Koen de Nijs, Mehrad Bastani, Vidit Munshi, Mehdi Hemmati, Kevin Ten Haaf, Jihyoun Jeon, Martin Carl Tammemägi, G Scott Gazelle, Eric J Feuer, Chung Yin Kong, Rafael Meza, Harry de Koning, Sylvia K Plevritis, Summer S Han
Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis. Annals of internal medicine 176 (3) (2023)
Lindy M Kregting, Nicolien T van Ravesteyn, Sarocha Chootipongchaivat, Eveline A M Heijnsdijk, Johannes D M Otten, Mireille J M Broeders, Harry de Koning
Cumulative risks of false positive recall and screen-detected breast cancer after multiple screening examinations. International journal of cancer (2023)
Iakovos Toumazis, Pianpian Cao, Koen de Nijs, Mehrad Bastani, Vidit Munshi, Mehdi Hemmati, Kevin Ten Haaf, Jihyoun Jeon, Martin Carl Tammemägi, G Scott Gazelle, Eric J Feuer, Chung Yin Kong, Rafael Meza, Harry de Koning, Sylvia K Plevritis, Summer S Han
Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis. Annals of internal medicine (2023)
Nadine Zielonke, Carlo Senore, Antonio Ponti, Marcell Csanádi, Harry de Koning, Eveline A M Heijnsdijk, Nicolien T van Ravesteyn
Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy. Journal of medical screening (2023)
Nicolien T van Ravesteyn, Clyde B Schechter, John M Hampton, Oguzhan Alagoz, Jeroen J van den Broek, Karla Kerlikowske, Jeanne S Mandelblatt, Diana L Miglioretti, Brian L Sprague, Natasha K Stout, Harry de Koning, Amy Trentham-Dietz, Anna N A Tosteson, null null
Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women. Journal of the National Cancer Institute 113 (8) (2022)
Miriam P van der Meulen, Esther Toes-Zoutenkijk, Manon C W Spaander, Evelien Dekker, Johannes M G Bonfrer, Anneke J van Vuuren, Ernst J Kuipers, Folkert J van Kemenade, M F van Velthuysen, Maarten G J Thomeer, Harriët van Veldhuizen, Harry de Koning, Iris Lansdorp-Vogelaar, Monique E van Leerdam
Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing. PloS one 17 (2) (2022)
Daan Ties, Paulien van Dorp, Gabija Pundziute, Erik Lipsic, Carlijn M van der Aalst, Matthijs Oudkerk, Harry de Koning, Rozemarijn Vliegenthart, Pim van der Harst
Multi-Modality Imaging for Prevention of Coronary Artery Disease and Myocardial Infarction in the General Population: Ready for Prime Time? Journal of clinical medicine 11 (11) (2022)
Esmée K J van der Poort, Nicolien T van Ravesteyn, Jeroen J van den Broek, Harry de Koning
The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs. Cancers 14 (12) (2022)
Lindy M Kregting, Valérie D V Sankatsing, Eveline A M Heijnsdijk, Harry de Koning, Nicolien T van Ravesteyn
Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modelled strategies. International journal of cancer 151 (2) (2022)
Lindy M Kregting, Valérie D V Sankatsing, Eveline A M Heijnsdijk, Harry de Koning, Nicolien T van Ravesteyn
Reply to: Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies". International journal of cancer 151 (4) (2022)
Pere Ginès, Laurent Castera, Frank Lammert, Isabel Graupera, Miquel Serra-Burriel, Alina M Allen, Vincent Wai-Sun Wong, Phillipp Hartmann, Maja Thiele, Llorenç Caballeria, Robert J de Knegt, Ivica Grgurevic, Salvador Augustin, Emmanuel A Tsochatzis, Jörn Markus Schattenberg, Indra Neil Guha, Andrea Martini, Rosa M Morillas, Montserrat Garcia-Retortillo, Harry de Koning, Núria Fabrellas Padrés, Judit Pich, Ann T Ma, M Alba Diaz, Dominique Roulot, Philip Noel Newsome, Michael Manns, Patrick S Kamath, Aleksander Krag, null null
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology (Baltimore, Md.) (2021)
Eveline A M Heijnsdijk, Steven J Supit, Leendert H J Looijenga, Harry de Koning
Screening for cancers with a good prognosis: The case of testicular germ cell cancer. Cancer medicine 10 (8) (2021)
Abraham M Getaneh, Eveline A M Heijnsdijk, Harry de Koning
Cost-effectiveness of multiparametric magnetic resonance imaging and MRI-guided biopsy in a population-based prostate cancer screening setting using a micro-simulation model. Cancer medicine 10 (12) (2021)
Stefanie G A Veenhuizen, Stéphanie V de Lange, Marije F Bakker, Ruud M Pijnappel, Ritse M Mann, Evelyn M Monninkhof, Marleen J Emaus, Petra K de Koekkoek-Doll, Robertus H C Bisschops, Marc B I Lobbes, Mathijn D F de Jong, Katya M Duvivier, Jeroen Veltman, Nico Karssemeijer, Harry de Koning, Paul J van Diest, Willem P T M Mali, Maurice A A J van den Bosch, Carla Henrica van Gils, Wouter B Veldhuis, null null
Supplemental Breast MRI for Women with Extremely Dense Breasts: Results of the Second Screening Round of the DENSE Trial. Radiology 299 (2) (2021)
Kevin Ten Haaf, Carlijn M van der Aalst, Harry de Koning, Rudolf Kaaks, Martin C Tammemägi
Personalising lung cancer screening: An overview of risk-stratification opportunities and challenges. International journal of cancer 149 (2) (2021)
Amir-Houshang Omidvari, Iris Lansdorp-Vogelaar, Harry de Koning, Reinier G S Meester
Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration. PloS one 16 (7) (2021)
Arthur I Kooyker, Esther Toes-Zoutenkijk, Annemieke W J Opstal-van Winden, Manon C W Spaander, Maaike Buskermolen, Hanneke J van Vuuren, Ernst J Kuipers, Folkert J van Kemenade, Chris Ramakers, Maarten G J Thomeer, Evelien Dekker, Iris D Nagtegaal, Harry de Koning, Monique E van Leerdam, Iris Lansdorp-Vogelaar
The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening. International journal of cancer 147 (4) (2020)
Abraham M Getaneh, Eveline A M Heijnsdijk, Monique J Roobol, Harry de Koning
Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios. Cancer medicine 9 (20) (2020)
Nadine Zielonke, Lindy M Kregting, Eveline A M Heijnsdijk, Piret Veerus, Sirpa Heinävaara, Martin McKee, Inge M C M de Kok, Harry de Koning, Nicolien T van Ravesteyn, null null
The potential of breast cancer screening in Europe. International journal of cancer 148 (2) (2020)
Giulia Veronesi, David R Baldwin, Claudia I Henschke, Simone Ghislandi, Sergio Iavicoli, Matthijs Oudkerk, Harry de Koning, Joseph Shemesh, John K Field, Javier J Zulueta, Denis Horgan, Lucia Fiestas Navarrete, Maurizio Valentino Infante, Pierluigi Novellis, Rachael L Murray, Nir Peled, Cristiano Rampinelli, Gaetano Rocco, Witold Rzyman, Giorgio Vittorio Scagliotti, Martin C Tammemagi, Lorenzo Spaggiari, Natthaya Triphuridet, Rowena Yip, Alexia Rossi, Suresh Senan, Giuseppe Ferrante, Kate Brain, Carlijn van der Aalst, Lorenzo Bonomo, Dario Consonni, Jan P Van Meerbeeck, Patrick Maisonneuve, Silvia Novello, Anand Devaraj, Zaigham Saghir, Giuseppe Pelosi
Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe. Cancers 12 (6) (2020)
Valérie D V Sankatsing, Nicolien T van Ravesteyn, Eveline A M Heijnsdijk, Mireille J M Broeders, Harry de Koning
Risk stratification in breast cancer screening: Cost-effectiveness and harm-benefit ratios for low-risk and high-risk women. International journal of cancer 147 (11) (2020)
Valérie D V Sankatsing, Karolina Juraniec, Sabine Elisabeth Grimm, Manuela A Joore, Ruud M Pijnappel, Harry de Koning, Nicolien T van Ravesteyn
Cost-effectiveness of Digital Breast Tomosynthesis in Population-based Breast Cancer Screening: A Probabilistic Sensitivity Analysis. Radiology 297 (1) (2020)
Marcell Csanádi, Andrea Gini, Harry de Koning, György Széles, János G Pitter, Beatrix Oroszi, Piroska Pataki, Petra Fadgyas-Freyler, Gyula Korponai, Zoltán Vokó, Iris Lansdorp-Vogelaar
Modeling costs and benefits of the organized colorectal cancer screening programme and its potential future improvements in Hungary. Journal of medical screening 28 (3) (2020)
Nora Pashayan, Antonis C Antoniou, Urška Ivanuš, Laura J Esserman, Douglas F Easton, David P French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans, Jacques Simard, Montserrat Garcia-Closas, Rita Schmutzler, Odette Wegwarth, Paul D P Pharoah, Sowmiya Moorthie, Sandrine De Montgolfier, Camille Baron, Zdenko Herceg, Clare Turnbull, Corinne Balleyguier, Paolo Giorgi Rossi, Jelle Wesseling, David Ritchie, Marc Tischkowitz, Mireille Broeders, Dan Reisel, Andres Metspalu, Thomas Callender, Harry de Koning, Peter Devilee, Suzette Delaloge, Marjanka K Schmidt, Martin Widschwendter
Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nature reviews. Clinical oncology 17 (11) (2020)
Erik E L Jansen, Steffie K Naber, Clare A Aitken, Harry de Koning, M van Ballegooijen, Inge M C M de Kok
Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling study. BJOG : an international journal of obstetrics and gynaecology 128 (3) (2020)
Tom Van Ourti, Owen O'Donnell, Hale Koç, Jacques Fracheboud, Harry de Koning
Effect of screening mammography on breast cancer mortality: Quasi-experimental evidence from rollout of the Dutch population-based program with 17-year follow-up of a cohort. International journal of cancer 146 (8) (2019)
Eveline A M Heijnsdijk, Marcell Csanádi, Andrea Gini, Kevin Ten Haaf, Rita Bendes, Ahti Anttila, Carlo Senore, Harry de Koning
All-cause mortality versus cancer-specific mortality as outcome in cancer screening trials: A review and modeling study. Cancer medicine 8 (13) (2019)

Harry de Koning.css-eqlu8i{font-size:small;padding-left:4px;} (H J de Koning, Harry J De Koning, Harry J de Koning)

Publication Activity (10 Years)

Top Topics

Top Venues

Harry de Koning (H J de Koning, Harry J De Koning, Harry J de Koning)